ライフサイエンスコーパス: indocyanine green

1 ation of theranostic agents (doxorubicin and indocyanine green).

2 following intravenous injection of 10 mg/kg indocyanine green.

3 stic signals compared with the commonly used indocyanine green.

4 t encapsulate the near infrared chromophore, indocyanine green.

5 The clinically applied hybrid tracer indocyanine green-(99m)Tc-nanocolloid enables combined r

6 e cancer during an SN biopsy procedure using indocyanine green-(99m)Tc-nanocolloid.

7 Indocyanine green and BPD angiography were performed in

8 ting (electrophysiology, fundus photography, indocyanine green and fluorescein angiography, and magne

9 mography (OCT), fundus autofluorescence, and indocyanine green and fluorescein angiography, was avail

10 nusoidal endothelial cells were evaluated by indocyanine green and hyaluronic acid uptake.

11 eceived a standardised cervical injection of indocyanine green and sentinel-lymph-node mapping follow

12 uated the in vivo uptake of hyaluronic acid, indocyanine green, and radio-labeled sulphur colloid to

13 he success rate of laser treatment guided by indocyanine green angiographic findings can vary conside

14 in an area of hypofluorescence on late-phase indocyanine green angiographic images.

15 ng color fundus photography, fluorescein and indocyanine green angiographies, spectral-domain optical

16 Indocyanine green angiography (ICG) was used to identify

17 s photography, fluorescein angiography (FA), indocyanine green angiography (ICG), optical coherence t

18 To investigate indocyanine green angiography (ICGA) findings in patient

19 Concurrent fluorescein angiography (FA) and indocyanine green angiography (ICGA) images were used to

20 escence (FAF), fluorescein angiography (FA), indocyanine green angiography (ICGA), and SD-OCT were pe

21 hy (OCTA), fluorescein angiography (FA), and indocyanine green angiography (ICGA), and the images fro

22 imultaneous fluorescein angiography (FA) and indocyanine green angiography (ICGA), enhanced-depth ima

23 eflectance, fundus autofluorescence imaging, indocyanine green angiography (ICGA), preferential hyper

24 obtained using fluorescein angiography (FA), indocyanine green angiography (ICGA), structural optical

25 rate vitritis, and hypocyanescent lesions on indocyanine green angiography (ICGA).

26 CT, OCT-A, fluorescein angiography (FA), and indocyanine green angiography (ICGA).

27 Baseline fluorescein angiography and indocyanine green angiography also were performed.

28 Advances in imaging, particularly in indocyanine green angiography and optical coherence tomo

29 patients with extrafoveal PCV, confirmed on indocyanine green angiography and treated with argon las

30 In dry macular degeneration, indocyanine green angiography appears to add clinically

31 In certain circumstances, indocyanine green angiography can be valuable in detecti

32 Indocyanine green angiography confirmed choroidal inflam

33 vidence of retinal vasculitis or papillitis, indocyanine green angiography evidence of active choroid

34 Indocyanine green angiography has allowed us to look at

35 For the past year, indocyanine green angiography has been applied to evalua

36 sarcoidosis in intraocular inflammation, and indocyanine green angiography has clarified choroidal in

37 The relative safety of indocyanine green angiography has contributed to its con

38 developments in the clinical application of indocyanine green angiography have mainly concerned refi

39 ptical coherence tomography, fluorescein and indocyanine green angiography in a 66 years old man suff

40 rrelated with the polypoidal lesions seen on indocyanine green angiography in all PCV eyes.

41 erns of abnormal hyperfluorescence seen with indocyanine green angiography in eyes with both wet and

42 al coherence tomography, and fluorescein and indocyanine green angiography in patients suspected of h

43 udies demonstrating choroidal involvement by indocyanine green angiography in patients with HTLV-1-as

44 Indocyanine green angiography is improving our understan

45 Indocyanine green angiography revealed the presence of c

46 d 1970s, the introduction of fluorescein and indocyanine green angiography revolutionized our ability

47 was confirmed by fluorescein angiography and indocyanine green angiography testing.

48 nding hypofluorescence in 100% of cases when indocyanine green angiography was performed.

49 us examination, fluorescein angiography, and indocyanine green angiography were included.

50 olor images, and fluorescein angiography and indocyanine green angiography were measured before and a

51 Fluorescein and indocyanine green angiography were performed in patients

52 FA), optical coherence tomography (OCT), and indocyanine green angiography were performed.

53 dalities such as magnetic resonance imaging, indocyanine green angiography, and digital image analysi

54 as ultrasonography, fluorescein angiography, indocyanine green angiography, and magnetic resonance im

55 rements, fundus photography, fluorescein and indocyanine green angiography, and microperimetry.

56 uorescence imaging, fluorescein angiography, indocyanine green angiography, and optical coherence tom

57 Ophthalmic CT, fluorescein angiography, indocyanine green angiography, and others are demonstrat

58 ser ophthalmoscopy, fluorescein angiography, indocyanine green angiography, and spectral-domain optic

59 ncluding fundus photography, fluorescein and indocyanine green angiography, fundus autofluorescence i

60 color photography, fluorescein angiography, indocyanine green angiography, near-infrared reflectance

61 amination including fluorescein angiography, indocyanine green angiography, spectral-domain optical c

62 for fluorescence, including fluorescein and indocyanine green angiography.

63 lar evaluation by a simultaneous fluorescein/indocyanine green angiography.

64 good correlation with lesions identified on indocyanine green angiography.

65 t, and regression of polypoidal complexes on indocyanine green angiography.

66 omography, fluorescein angiography (FA), and indocyanine green angiography.

67 erence tomography (OCT), and fluorescein and indocyanine green angiography.

68 Indocyanine-green angiography (ICG-A) may be considered

69 tofluorescence, fluorescein angiography, and indocyanine-green angiography (ICGA).

70 Trypan Blue and Indocyanine Green appear to be most effective in stainin

71 At the time of reperfusion, indocyanine green-based in vivo imaging showed that CD47

72 Administration-cleared devices designed for indocyanine green-based perfusion imaging to identify ca

73 Intraoperative visualization of the SLN by indocyanine green before skin incision was successful in

74 tly faster lymphatic drainage as measured by indocyanine green clearance and increased lymphatic vess

75 llular function was determined by an in vivo indocyanine green clearance technique.

76 Indocyanine green clearance was measured in two animals

77 lationship between the increments in VO2 and indocyanine green clearance was observed (r2 = .21; p =

78 e maximal velocity and efficiency of in vivo indocyanine green clearance) was determined and hepatocy

79 l velocity and overall efficiency of in vivo indocyanine green clearance) were assessed at 24 hours a

80 ximum velocity and the overall efficiency of indocyanine green clearance) were determined at 4 hrs af

81 ximum velocity and the overall efficiency of indocyanine green clearance) were determined.

82 Indocyanine green clearance, as determined by a fiberopt

83 A noninvasive measurement of indocyanine green clearance, the plasma disappearance ra

84 velocity and transport efficiency of in vivo indocyanine green clearance.

85 , N-acetylcysteine elicits an improvement in indocyanine green clearance.

86 ut not VO2) and a nonsignificant increase in indocyanine green clearance.

87 The number of new indications for indocyanine green continues to increase, including innov

88 ulating blood volume were assessed using the indocyanine green dilution technique and a left ventricu

89 When indocyanine green dosages were 10 microg or higher, lymp

90 Indocyanine green dye (0.08 mg/ml in D5W) was injected s

91 EGF-Cy5.5, but not Cy5.5 or indocyanine green dye (ICG), bound to MDA-MB-468 cells.

92 ith 50- to 100-fold greater concentration of Indocyanine Green dye over background levels.

93 f the PKWS subject that transported injected indocyanine green dye to the inguinal lymph node and dra

94 Near-infrared reflectance measurements of indocyanine green dye uptake indicated that there were n

95 Indocyanine green dye was used as a nonspecific control

96 ining of the internal limiting membrane with indocyanine green dye, and variations in the length of p

97 Indocyanine green elimination constants (K(ICG)) were me

98 Based upon Indocyanine Green encapsulation within the nanoparticles

99 al nonimmobilized limb, confirmed by in vivo indocyanine green-enhanced NIR optical imaging (3.86-fol

100 of muscle damage was obtained using in vivo indocyanine green-enhanced NIR optical imaging, magnetic

101 Fusion of indocyanine green-enhanced optical imaging and radiograp

102 Indocyanine green-enhanced optical imaging is a clinical

103 Fusion of indocyanine green-enhanced optical imaging scans with ra

104 Mean rates of bile flow, biliary indocyanine green excretion, and bile acid flux were sig

105 Indocyanine green fluorescence imaging is a surgical too

106 ependent or that refine the existing method: indocyanine green fluorescence, contrast-enhanced ultras

107 cutaneous melanoma on the trunk), the use of indocyanine green for SLN detection is severely limited

108 TATION: Sentinel lymph nodes identified with indocyanine green have a high degree of diagnostic accur

109 ode tracer consisting of the fluorescent dye indocyanine green (ICG) and (99m)Tc-nanocolloid with the

110 Indocyanine green (ICG) and epirubicin (EPI) could co-se

111 in infrared reflectance (IR) photographs and indocyanine green (ICG) angiograms.

112 orescence (FAF), and fluorescein angiography/indocyanine green (ICG) angiography findings, of patient

113 glycated chitosan (GC) as immunoadjuvant and indocyanine green (ICG) as laser-absorbing dye have show

114 infrared (NIR) range, clinical potential of indocyanine green (ICG) as PT is limited by its short ha

115 Liver function was assessed by clearance of indocyanine green (ICG) at 4, 20 and 28 hours.

116 ood flow and function were determined by the indocyanine green (ICG) clearance test.

117 The near-infrared dye indocyanine green (ICG) could serve as a basis for such

118 otic shock technique was used to encapsulate indocyanine green (ICG) dye in erythrocyte ghost cells a

119 /J mice was induced by combined injection of indocyanine green (ICG) dye into the anterior chamber an

120 espectively tracked iron oxide particles and indocyanine green (ICG) encapsulated in the NPs as trace

121 ogenase (LDH) activity, bile production, and indocyanine green (ICG) extraction.

122 tomography (DOT) after the administration of indocyanine green (ICG) for contrast enhancement.

123 Hyperfluorescent cells labeled with indocyanine green (ICG) have been observed in retinal an

124 I) using an intraoperative injection of free indocyanine green (ICG) in the detection of peritoneal m

125 sed signal strength by as much as 36.3%, and indocyanine green (ICG) increased signal magnitudes by a

126 ceived 0.5 mg per kilogram of body weight of indocyanine green (ICG) intravenously 24 hours prior to

127 on and lower autofluorescence; however, only indocyanine green (ICG) is clinically approved.

128 -enhanced Raman scattering (SERS) studies on indocyanine green (ICG) on colloidal silver and gold and

129 The data indicated that (1) formulated indocyanine green (ICG) readily penetrated hyperkeratoti

130 study was to evaluate the performance of the indocyanine green (ICG) retention test as a noninvasive

131 Both indocyanine green (ICG) solution and TA suspension, at 5

132 Indocyanine green (ICG) was administered intravenously 1

133 as been uniquely accomplished with NIR using indocyanine green (ICG), a nonspecific dye that has comp

134 Here we report that indocyanine green (ICG), an infrared fluorescent dye wit

135 lowly releasing a pressurized cuff occluding indocyanine green (ICG), demonstrated an increase in ves

136 tein (GFP), tricarbocyanine 5.5 (Cy5.5), and indocyanine green (ICG), filters were selected to allow

137 e well-known and widely used fluorescent dye indocyanine green (ICG), which has FDA approval, exhibit

138 ntraprostatic injection of the hybrid tracer indocyanine green (ICG)-(99m)Tc-nanocolloid enables both

139 The fluorophore outperformed indocyanine green (ICG)-a clinically approved NIR-I dye-

140 rs, and 24 hours after systemic injection of indocyanine green (ICG).

141 ugated with a near-infrared fluorescent dye [indocyanine green (ICG)] targets low extracellular pH, a

142 Fluorescein (FA) and indocyanine green (ICGA) angiography (Heidelberg Spectra

143 direct cannulation, perivascular flowprobe, indocyanine green imaging, and functional magnetic reson

144 l subcutaneous injections of 0.31-100 microg indocyanine green in the breast in this IRB-approved, HI

145 Hepatic blood flow was determined by indocyanine green infusion.

146 l retrospective studies, the fluorescent dye indocyanine green is considered a possible alternative t

147 Using relatively high doses of indocyanine green, long-term enhanced fluorescence of ar

148 Lymph imaging consistently failed with indocyanine green microdosages between 0.31 and 0.77 mic

149 ontrast-enhanced magnetic resonance imaging, indocyanine green near-infrared imaging, and intravital

150 In patients who received 10 microg of indocyanine green or more, a weak negative correlation b

151 By the direct Fick, or the indocyanine-green or both, methods and by renal clearanc

152 gent mixture composed of fluorescein sodium, indocyanine green, PCM102, and PCM107 and imaged with a

153 tic function (transpulmonary thermodilution, indocyanine green plasma disappearance rate [ICG-PDR]) w

154 Immediately after administration, indocyanine green provided a significant increase in the

155 /-0.5 vs. 33.2+/-1.7 microg/min/g liver) and indocyanine green secretion (11.7+/-1.7 vs. 21.2+/-2.1 A

156 usion model, lactate dehydrogenase activity, indocyanine green secretion, and portal pressure values

157 of the feature sizes of a common NIR I dye (indocyanine green) showed a more rapid loss of feature c

158 antitative liver function tests, such as the indocyanine green test and galactose elimination capacit

159 , and an ex vivo spectrophotometric assay of indocyanine green uptake (1.87-fold increase in normaliz

160 ated similar hyaluronic acid uptake, whereas indocyanine green uptake was markedly impaired in the hy

161 perfusion) and in vivo (hyaluronic acid and indocyanine green uptake, arterial ketone body ratio, or

162 At anesthesia induction, indocyanine green was injected intravenously.

163 that contained micromolar concentrations of indocyanine green with 1:0 and 100:1 target-to-backgroun